Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Net Margin (2023 - 2025)

Historic Net Margin for Inhibrx Biosciences (INBX) over the last 3 years, with Q2 2025 value amounting to 2204.15%.

  • Inhibrx Biosciences' Net Margin fell 18602151500.0% to 2204.15% in Q2 2025 from the same period last year, while for Sep 2025 it was 12031.5%, marking a year-over-year increase of 377267300.0%. This contributed to the annual value of 843786.0% for FY2024, which is 8571041700.0% up from last year.
  • Inhibrx Biosciences' Net Margin amounted to 2204.15% in Q2 2025, which was down 18602151500.0% from 1610.67% recorded in Q1 2025.
  • Inhibrx Biosciences' 5-year Net Margin high stood at 1858011.0% for Q2 2024, and its period low was 156840.0% during Q2 2023.
  • Its 3-year average for Net Margin is 200566.5%, with a median of 3916.34% in 2025.
  • Its Net Margin has fluctuated over the past 5 years, first surged by 2000000000bps in 2024, then crashed by 2000000000bps in 2025.
  • Over the past 3 years, Inhibrx Biosciences' Net Margin (Quarter) stood at 5628.52% in 2023, then tumbled by -750bps to 47865.0% in 2024, then surged by 95bps to 2204.15% in 2025.
  • Its Net Margin was 2204.15% in Q2 2025, compared to 1610.67% in Q1 2025 and 47865.0% in Q4 2024.